Loading…
Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study
Scoccimarro, Daniele, Cipani, Giacomo, Dicembrini, Ilaria, Mannucci, Edoardo
Published in Diabetes/metabolism research and reviews (01.02.2024)
Published in Diabetes/metabolism research and reviews (01.02.2024)
Get full text
Journal Article
Loading…
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
Mone, Pasquale, Varzideh, Fahimeh, Jankauskas, Stanislovas S., Pansini, Antonella, Lombardi, Angela, Frullone, Salvatore, Santulli, Gaetano
Published in Hypertension (Dallas, Tex. 1979) (01.08.2022)
Published in Hypertension (Dallas, Tex. 1979) (01.08.2022)
Get full text
Journal Article
Loading…
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
Wiviott, Stephen D., Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A., McGuire, Darren K., Wilding, John PH, Gause-Nilsson, Ingrid AM, Langkilde, Anna Maria, Johansson, Peter A., Sabatine, Marc S.
Published in The American heart journal (01.06.2018)
Published in The American heart journal (01.06.2018)
Get full text
Journal Article
Loading…
Interaction Between the Sodium‐Glucose–Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects
Wilcox, Christopher S., Shen, Wen, Boulton, David W., Leslie, Bruce R., Griffen, Steven C.
Published in Journal of the American Heart Association (20.02.2018)
Published in Journal of the American Heart Association (20.02.2018)
Get full text
Journal Article
Loading…
Loading…
Loading…
Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin
Polidori, David, Iijima, Hiroaki, Goda, Maki, Maruyama, Nobuko, Inagaki, Nobuya, Crawford, Peter A.
Published in Diabetes, obesity & metabolism (01.05.2018)
Published in Diabetes, obesity & metabolism (01.05.2018)
Get full text
Journal Article
Loading…
Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Proline Henagliflozin in Chinese Subjects with Varying Degrees of Liver Dysfunction
Ding, Likun, Yang, Lin, Ren, Danjun, Gao, Xiaohua, Zhang, Juanli, Liu, Meiyou, Sun, Li, Diao, Qingbo, Feng, Sheng, Wen, Aidong, Wang, Jingwen
Published in Journal of clinical pharmacology (01.08.2024)
Published in Journal of clinical pharmacology (01.08.2024)
Get more information
Journal Article
Loading…
Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10–17 years with type 2 diabetes mellitus
Rascher, Juliane, Cheng, Shen, Johnston, Curtis, Härtter, Sebastian, Jan‐Georg, Wojtyniak, Marquard, Jan, Tartakovsky, Igor, Laffel, Lori M. B.
Published in British journal of clinical pharmacology (01.08.2025)
Published in British journal of clinical pharmacology (01.08.2025)
Get full text
Journal Article
Loading…
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
Muller, Dion R. P., Stenvers, Dirk J., Malekzadeh, Arjan, Holleman, Frederik, Painter, Rebecca C., Siegelaar, Sarah E.
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Get full text
Journal Article
Loading…
Loading…
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure
Kasperova, Barbora Judita, Mraz, Milos, Svoboda, Petr, Hlavacek, Daniel, Kratochvilova, Helena, Modos, Istvan, Vrzackova, Nikola, Ivak, Peter, Janovska, Petra, Kobets, Tatyana, Mahrik, Jakub, Riecan, Martin, Steiner Mrazova, Lenka, Stranecky, Viktor, Netuka, Ivan, Cajka, Tomas, Kuda, Ondrej, Melenovsky, Vojtech, Stemberkova Hubackova, Sona, Haluzik, Martin
Published in Cardiovascular diabetology (28.06.2024)
Published in Cardiovascular diabetology (28.06.2024)
Get full text
Journal Article
Loading…
A systematic review on effect of sodium-glucose cotransporter-2 inhibitors on the metabolic and endocrinological profile of patients with polycystic ovarian syndrome
Roy, Madhura, Parveen, Rizwana, Khan, Parvej, Majid, Haya, Pathak, Mani, Saxena, Rajesh, Nidhi
Published in Expert opinion on pharmacotherapy (01.10.2024)
Published in Expert opinion on pharmacotherapy (01.10.2024)
Get more information
Journal Article
Loading…
The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
Cianciolo, Giuseppe, De Pascalis, Antonio, Gasperoni, Lorenzo, Tondolo, Francesco, Zappulo, Fulvia, Capelli, Irene, Cappuccilli, Maria, La Manna, Gaetano
Published in Molecules (Basel, Switzerland) (15.06.2020)
Published in Molecules (Basel, Switzerland) (15.06.2020)
Get full text
Journal Article
Loading…
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
Dharmalingam, Mala, Aravind, S. R., Thacker, Hemant, Paramesh, S., Mohan, Brij, Chawla, Manoj, Asirvatham, Arthur, Goyal, Ramesh, Shembalkar, Jayashri, Balamurugan, R., Kadam, Pradnya, Alva, Hansraj, Kodgule, Rahul, Tandon, Monika, Vaidyanathan, Sivakumar, Pendse, Amol, Gaikwad, Rajesh, Katare, Sagar, Suryawanshi, Sachin, Barkate, Hanmant
Published in Drugs (New York, N.Y.) (01.04.2020)
Published in Drugs (New York, N.Y.) (01.04.2020)
Get full text
Journal Article
Loading…
Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods
Song, Ling, Yao, Xueting, Liu, Yang, Zhong, Wen, Jiang, Ji, Liu, Hongzhong, Zhou, Huimin, Shi, Chongtie, Zong, Kaiqi, Wang, Chong, Ma, Chuanxiang, Liu, Dongyang, Hu, Pei
Published in European journal of pharmaceutical sciences (30.04.2020)
Published in European journal of pharmaceutical sciences (30.04.2020)
Get full text
Journal Article
Loading…
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
Tomita, Issei, Kume, Shinji, Sugahara, Sho, Osawa, Norihisa, Yamahara, Kosuke, Yasuda-Yamahara, Mako, Takeda, Naoko, Chin-Kanasaki, Masami, Kaneko, Tatsuroh, Mayoux, Eric, Mark, Michael, Yanagita, Motoko, Ogita, Hisakazu, Araki, Shin-ichi, Maegawa, Hiroshi
Published in Cell metabolism (01.09.2020)
Published in Cell metabolism (01.09.2020)
Get full text
Journal Article
Loading…
Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Wei, Ran, Wang, Weihao, Pan, Qi, Guo, Lixin
Published in Frontiers in endocrinology (Lausanne) (16.02.2022)
Published in Frontiers in endocrinology (Lausanne) (16.02.2022)
Get full text
Journal Article
Loading…